Navigation Links
Dermal in Biological Technology
Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
... patients who are looking for a longer lasting dermal filler. Dr. Ronel has been an avid Artefill user ... is injected with Artefill similar to other dermal fillers with the key difference being its lasting ... feeling results. This is different from temporary dermal fillers that are made of different kinds of ...Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler
... 12 months for EVOLENCE(R), a collagen-based dermal filler for the correction of moderate to deep ... EVOLENCE(R) is the first and only collagen dermal filler recognized to provide results through 12 ... initial treatment*. EVOLENCE(R), the first dermal filler entry for Ortho Dermatologics, was ...BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008
... update on its product pipeline: -- RADIESSE(R) dermal Filler Next-Generation Products: The Company has ... indications of its patent protected RADIESSE dermal filler technology. The first new commercial ... efforts is expected to be a form of RADIESSE dermal filler with Lidocaine which may improve ...... recent papers demonstrate safety with Radiesse(R) dermal filler in 1000 patients over 4 years, evidence ... in various prestigious journals, Radiesse dermal filler is one of the most rigorously studied ... the safety and effectiveness of Radiesse dermal filler in treatment of nasolabial folds, ...
... a patent protected combination, second generation dermal filler. dermal fillers are used to reverse changes associated ... with the baby boomers coming of age, and the US dermal filler market is projected to reach $1 billion by ...
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
... products for pain. Qutenza is a high-concentration capsaicin dermal patch designed to provide rapid, localized and sustained relief from ... late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain ...Palomar and Q-MED AB Terminate International Distribution Agreement
... Q-MED's efforts are being concentrated on their own product line of dermal fillers. Both Palomar and Q-MED agreed that Palomar will be better served ... present challenging market conditions, Q-Med is focusing on its leading dermal filler product line, Restylane(R) as well as on the on-going launch of ...... (PG) receptors. PG receptors are present in hair, particularly in the dermal papilla and outer root sheath. Although the precise mechanism of action ... portfolio, including BOTOX(R) Cosmetic; hyaluronic acid and collagen-based dermal fillers; and physician-dispensed skin care products. Allergan Medical ...
NeurogesX to Report Third Quarter 2008 Financial Results
... late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain ... a liquid, NGX-1998 is expected to be suitable for areas of the skin where dermal patches may be difficult or impractical to apply, such as the hairline. ...NeurogesX Reports Second Quarter 2008 Results
... late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain ... a liquid, NGX-1998 is expected to be suitable for areas of the skin where dermal patches may be difficult or impractical to apply, such as the hairline. ...NeurogesX Reports First Quarter 2008 Results
... development expected in second quarter of 2008 - NDA submission for dermal patch, NGX-4010, in PHN expected in second half ... late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain ...Palomar and Q-MED AB Enter Into International Distribution Agreement
... the producer of Restylane, one of the most popular and widely distributed dermal fillers in the world, with over 9 million treatments provided so far. ... effects of Palomar's light-based systems with Q- MED's leading range of dermal fillers and injectable implants. Both companies are focused on developing ...Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
... of creating a system which is poised to revolutionize the field of dermal drug delivery." The Challenges and Promise of Transdermal Delivery The ... a high dose of potent drug rapidly and painlessly reaches the affected dermal tissue, while the patient avoids the potential toxicity and adverse ...Echo Therapeutics Reports Third Quarter 2007 Results
... of well-established, FDA-approved products using Echo's AzoneTS dermal penetration enhancement technology in concert with a 505(b)(2) ... well-established, FDA-approved products using its proprietary AzoneTS(TM) dermal penetration technology. Echo has submitted a New Drug Application (NDA) to ...NeurogesX Reports Second Quarter 2009 Results
... (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the ...NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
... (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the ...NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
... (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza((TM)), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the ...... in the advanced injection techniques of Allergan products Juvederm and Botox, is on the Medical Education Faculty for Bioform's Radiesse long term dermal filler and also is a physician trainer for Restylane and Perlane and the new neurotoxin Dysport. He is the medical director of Total Dermatology, ...
High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu
... terms of all the major routes of exposure, oral, dermal and inhalation, it showed no harmful effects on humans. The BioMask(TM) has been tested for dermal biocompatibility following internationally recognized standards set out in ISO10933: Biological Evaluation of Medical Devices. Tests were conducted ...NeurogesX Added to Russell 3000 Index
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the ...Australia: Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight
... tested in terms of all the major routes of exposure, dermal and inhalation, it showed no harmful effects on humans. The BioMask has been tested for dermal biocompatibility following internationally recognized standards set out in ISO10933: Biological Evaluation of Medical Devices. Tests were conducted ...NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the ...... Total Dermatology, is located in Irvine, Ca. His clinic is a popular choice for all cosmetic dermatology applications, with a special focus on dermal fillers, Botox and lasers. Consultations are available by calling (949) 727 3800 or contacting the practice via their website ...
NeurogesX to Present at Needham Life Sciences Conference
... (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the ...NeurogesX Receives European Commission Approval for Qutenza(TM)
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the ...NeurogesX Reports First Quarter 2009 Results
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late-stage product portfolio is led by its product candidate QutenzaTM, a dermal high-concentration capsaicin patch designed to manage pain associated with peripheral neuropathic pain conditions. NeurogesX submitted a new drug ...NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. NeurogesX submitted a new drug application (NDA) for Qutenza to ...NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
... peripheral neuropathic pain, including PHN, HIV-DSP and PDN. NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over ...Histogen Aesthetics Launches ReGenica Rejuvenation System
... Rejuvenation System for anti-aging and post-resurfacing. Histogen Aesthetics utilizes a proprietary manufacturing process in which newborn dermal fibroblast cells are grown on beads in controlled bioreactors that maintain an embryonic-like environment, including low oxygen and low gravity ...... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over ...
NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late-stage product portfolio is led by its product candidate QutenzaTM, a dermal high concentration capsaicin patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers ...... medical use in migraine, back pain and TML Used along with fillers, Dr. Pilest finds that Botox also tends to typically prolong the effects of the dermal fillers by restricting muscle activity that drives filler component breakdown. Dr. Pilest enthuses, "For a fast, simple and practically ...
... human extracellular matrix which is grown in a simulated embryonic environment, is currently being evaluated for a variety of applications, from dermal fillers to implant coatings," said Dr. Robert Kellar, VP of Research and Development at Histogen. "Intriguing preliminary results from ...
Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans
... Australia, the Principal Investigator is Professor Allan Evans. The trial is an open label, single centre bioavailability and penetration trial of dermal and systemic pharmacokinetics in 12 healthy adult volunteers, incorporating secondary endpoints of safety and tolerability. The Company expects to ...NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over ...NeurogesX Reports Third Quarter 2008 Results
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over ...... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over ...
Histogen Aesthetics is Created to Address Growing Medical Aesthetics Market
... San Diego/Phoenix (PRWEB) October 20, 2008 -- Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn dermal fibroblasts, today announced the creation of Histogen Aesthetics LLC, a venture developing products for the growing medical aesthetic industries ...NeurogesX Responds to EMEA's Day 120 Questions
... polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over ...MIGENIX Reports First Quarter Fiscal 2009 Financial Results
... a NDA in 2011, Cutanea expects: - in the first quarter of calendar 2009, to initiate chronic toxicology studies, specifically the required dermal carcinogenicity study, which Cutanea expects will be the rate limiting activity for submission of the NDA; and - in the second half of ...Other ContentsOther Tags
(Date:5/18/2013)... Orlando, FL (May 18, 2013) An increasing ... that require interventions to resolve, according to research ... In one study targeting obesity, researchers at the ... have a unique pattern of exhaled breath compared ... in volatile organic compound levels that can be ...
(Date:5/17/2013)... Researchers at Rutgers, The State University of New Jersey, ... proprietary new formulation called Visikol TM that effectively ... be used in place of chloral hydrate, which is ... but which is tightly regulated by the Drug Enforcement ... , Clearing solutions, or clearing agents, are vital for ...
(Date:5/17/2013)... Tibetan antelope can live at elevations of 4,000-5,000m ... published in Nature Communications , investigators from ... that some genetic factors may be associated with ... data in this work will also provide implications ... of other ruminant species. , The Tibetan antelope ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2(Date:5/19/2013)... 19, 2013 Today, Zane Benefits, ... business health insurance . Zane Benefits, which provides ... health benefits, is the leader in health care ... reimbursement arrangements . , According to Zane Benefits’ ... intrinsically know the value of small business health ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The report ... Global Trends & Forecasts up to 2017” published by ... market with analysis and forecasting of the global volume ... identifies the driving and restraining factors for the global ... imperatives, and challenges. The market is segmented and revenue ...
(Date:5/19/2013)... Chertok now provides gum disease patients with a new alternative ... of a healthier smile. Laser gum surgery or ... diseased gum tissue in patients, but it also stimulates bone ... , LANAP uses a laser to successfully treat and ... healthy tissue as well as encourage new bone growth. With ...
(Date:5/19/2013)... St. Petersburg, FL (PRWEB) May 19, 2013 ... Sublime Beauty ®, who is reintroducing a great practice ... today. "Skin Brushing, also known as dry body brushing, ... says Kathy Heshelow, founder of Sublime Beauty®. "We love ... that functioning of our largest organ, the skin, is ...
(Date:5/19/2013)... Ponte Vedra Beach, Florida (PRWEB) May 19, 2013 ... healthcare value and market access, is pleased to unveil ... online trade show environment that provides a powerful array ... solutions to partners in the US and abroad. , ... technology, and will offer attendees the look and feel ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3[0] Zane Benefits Publishes New Information on Small Business Health Insurance[0] Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets[0] Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants[0] Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret[0] HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access
Ser8ActopaxinHamartinSYT16Ser675SIAHPerCPAPCBDFastImmuneNaked1Ser345PhosphothreonineRNLNeuroendocrine
Other Tags| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |